158 related articles for article (PubMed ID: 16118084)
1. Impressive regression of primary liver cancer after treatment with sirolimus.
Rizell M; Cahlin C; Friman S; Hafström L; Lönn L; Olausson M; Lindner P
Acta Oncol; 2005; 44(5):496. PubMed ID: 16118084
[No Abstract] [Full Text] [Related]
2. Hepatocellular cancer, transplantation, and sirolimus.
Wall WJ
Liver Transpl; 2004 Oct; 10(10):1312-4. PubMed ID: 15376337
[No Abstract] [Full Text] [Related]
3. Pilot study: rapamycin in advanced hepatocellular carcinoma.
Schöniger-Hekele M; Müller C
Aliment Pharmacol Ther; 2010 Sep; 32(6):763-8. PubMed ID: 20629977
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant conversion to sirolimus in liver transplant patients with recurrent hepatocellular carcinoma - preliminary results.
Kornberg A; Küpper B; Tannapfel A; Thrum K; Wilberg J; Bärthel E; Settmacher U
Transpl Int; 2008 Jan; 21(1):96-9. PubMed ID: 17903182
[No Abstract] [Full Text] [Related]
5. Activation of the mammalian target of rapamycin signaling pathway in hepatocellular carcinoma.
Subbiah IM; Brown RE; Fallon MB
Hepatology; 2010 Oct; 52(4):1524. PubMed ID: 20680964
[No Abstract] [Full Text] [Related]
6. Spontaneous complete necrosis of hepatocellular carcinoma: a case report.
Li AJ; Wu MC; Cong WM; Shen F; Yi B
Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):152-4. PubMed ID: 14607670
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous regression of hepatocellular carcinoma.
Sibartie V; Moriarty J; Crowe J
Am J Gastroenterol; 2008 Apr; 103(4):1050-1. PubMed ID: 18397439
[No Abstract] [Full Text] [Related]
8. [Basic and clinical study of interferon a in hepatocellular carcinoma].
Sun HC; Wang L; Wu WZ
Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1606-8. PubMed ID: 19094750
[No Abstract] [Full Text] [Related]
9. [Autopsy case of liver cancer undetected until the terminal stage].
Hattori M; Katsuta K; Hozumi M
Iryo; 1970 Mar; 24(3):249-55. PubMed ID: 4316183
[No Abstract] [Full Text] [Related]
10. Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria.
Zhou J; Wang Z; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY; Fan J
Transplant Proc; 2008 Dec; 40(10):3548-53. PubMed ID: 19100435
[TBL] [Abstract][Full Text] [Related]
11. De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects.
Toso C; Meeberg GA; Bigam DL; Oberholzer J; Shapiro AM; Gutfreund K; Ma MM; Mason AL; Wong WW; Bain VG; Kneteman NM
Transplantation; 2007 May; 83(9):1162-8. PubMed ID: 17496530
[TBL] [Abstract][Full Text] [Related]
12. Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience.
Zimmerman MA; Trotter JF; Wachs M; Bak T; Campsen J; Wright F; Steinberg T; Bennett W; Kam I
Transpl Int; 2007 Sep; 20(9):747-53. PubMed ID: 17565579
[TBL] [Abstract][Full Text] [Related]
13. Systemic treatment in advanced/metastatic hepatocellular carcinoma in the era of targeted therapy.
Han KH; Park JY
J Gastroenterol Hepatol; 2010 Jun; 25(6):1023-5. PubMed ID: 20594213
[No Abstract] [Full Text] [Related]
14. [Spontaneous regression of hepatocellular carcinoma].
Ledesma S; Boada L; Titó L; Armengol S; Torres M
Gastroenterol Hepatol; 1998 Nov; 21(9):469-70. PubMed ID: 9882942
[No Abstract] [Full Text] [Related]
15. Cirrhotomimetic type hepatocellular carcinoma diagnosed after liver transplantation--eighteen months of follow-up: a case report.
Han YS; Choi DL; Park JB
Transplant Proc; 2008 Oct; 40(8):2835-6. PubMed ID: 18929876
[TBL] [Abstract][Full Text] [Related]
16. Polyprenoic acid in hepatocellular carcinoma.
Yang CH; Cheng AL
N Engl J Med; 1996 Nov; 335(19):1460-61; author reply 1461-2. PubMed ID: 8927081
[No Abstract] [Full Text] [Related]
17. Evaluation of a chemotherapeutic regimen for primary liver cancer in children.
Senzer NN; Terrell W; Pratt CB
Cancer Treat Rep; 1978 Sep; 62(9):1403-4. PubMed ID: 210945
[No Abstract] [Full Text] [Related]
18. Successful treatment with low-dose oral chemotherapy in a patient with metastatic hepatocellular carcinoma.
Di Meglio G; Fazio N; Nolè F; Della Vigna P; Lorizzo K; Goldhirsch A; Farris A
Acta Oncol; 2007; 46(8):1205-6. PubMed ID: 17978934
[No Abstract] [Full Text] [Related]
19. Polyprenoic acid in hepatocellular carcinoma.
Decensi A; Costa A
N Engl J Med; 1996 Nov; 335(19):1461; author reply 1461-2. PubMed ID: 8927082
[No Abstract] [Full Text] [Related]
20. Spontaneous regression of hepatocellular carcinoma with complete necrosis: case report.
Ohta H; Sakamoto Y; Ojima H; Yamada Y; Hibi T; Takahashi Y; Sano T; Shimada K; Kosuge T
Abdom Imaging; 2005; 30(6):734-7. PubMed ID: 16252150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
